The African swine fever (or ASF) epidemic that has
devastated herds in China (as well as Vietnam and other Asian nations)
has spiked global prices, creating a temporary windfall opportunity for
exporters like BRF S.A. (BRFS) and JBS (OTCQX:JBSAY).
At the same time, though, BRF has been making steady progress in its
turnaround efforts and has been able to use the ASF windfall to
accelerate its leverage reduction targets.
I thought BRF shares looked a little overheated
in late August, but with the stock down about 15% since then, I'm more
bullish on these shares. BRF still has a lot left on its "to do" list,
but new management has built up some meaningful credibility, and it's
easier to see the path towards a much stronger, more competitive BRF.
Read the full article here:
Swine Fever And Self-Improvement Leading To Real Progress At BRF
No comments:
Post a Comment